Hailong Guo

Summary

Publications

  1. pmc Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus
    Hailong Guo
    Center for Infectious Diseases and Vaccine Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA
    J Virol 88:12006-16. 2014
  2. pmc Multiple distinct forms of CD8+ T cell cross-reactivity and specificities revealed after 2009 H1N1 influenza A virus infection in mice
    Hailong Guo
    Center for Infectious Diseases and Vaccine Immunology, Rochester General Hospital Research Institute, Rochester, New York, United States of America
    PLoS ONE 7:e46166. 2012
  3. pmc Protection against lethal influenza with a viral mimic
    Steven F Baker
    Department of Microbiology and Immunology, University of Rochester, Rochester, New York, USA
    J Virol 87:8591-605. 2013
  4. pmc Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection
    Hailong Guo
    Department of Microbiology and Immunology and David H Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, University of Rochester, Rochester, New York 14642, USA
    J Virol 84:7750-9. 2010
  5. pmc T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model
    Hailong Guo
    David H Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 609, Rochester, NY 14642, USA
    J Virol 85:448-55. 2011

Collaborators

Detail Information

Publications5

  1. pmc Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus
    Hailong Guo
    Center for Infectious Diseases and Vaccine Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA
    J Virol 88:12006-16. 2014
    ..Thus, our results demonstrate the potential for sciIV as a CD8 T cell-inducing vaccine...
  2. pmc Multiple distinct forms of CD8+ T cell cross-reactivity and specificities revealed after 2009 H1N1 influenza A virus infection in mice
    Hailong Guo
    Center for Infectious Diseases and Vaccine Immunology, Rochester General Hospital Research Institute, Rochester, New York, United States of America
    PLoS ONE 7:e46166. 2012
    ..These observations demonstrate unusual CD8+ T cell cross-reactivity and specificity are elicited after primary and secondary CA/E3/09 influenza virus infections...
  3. pmc Protection against lethal influenza with a viral mimic
    Steven F Baker
    Department of Microbiology and Immunology, University of Rochester, Rochester, New York, USA
    J Virol 87:8591-605. 2013
    ..All together, our studies suggest that sciIV may have potential as a broadly protective vaccine against influenza virus. ..
  4. pmc Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection
    Hailong Guo
    Department of Microbiology and Immunology and David H Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, University of Rochester, Rochester, New York 14642, USA
    J Virol 84:7750-9. 2010
    ..Our data suggest that during primary respiratory viral infection, IL-22 seems to a play a marginal role for protection, indicating a differential requirement of this cytokine for bacterial and viral infections...
  5. pmc T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model
    Hailong Guo
    David H Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 609, Rochester, NY 14642, USA
    J Virol 85:448-55. 2011
    ..Our results highlight the importance of establishing cross-reactive T-cell responses for protecting against existing or newly emerging pandemic influenza viruses...